| scholarly article | Q13442814 |
| P50 | author | Shugo Mizuno | Q61165828 |
| Hiroyuki Sakurai | Q87707156 | ||
| Shuji Isaji | Q87707158 | ||
| Aoi Hayasaki | Q90731894 | ||
| Naohisa Kuriyama | Q90731897 | ||
| Yasuhiro Murata | Q91964018 | ||
| P2093 | author name string | Hiroyuki Kato | |
| Masanobu Usui | |||
| Katsunori Uchida | |||
| Masashi Kishiwada | |||
| Yoshinori Azumi | |||
| Akihiro Tanemura | |||
| Yusuke Iizawa | |||
| Takehiro Fujii | |||
| Taemi Hibi | |||
| P2860 | cites work | Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages | Q21092323 |
| A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreat | Q33820943 | ||
| Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis | Q34380033 | ||
| Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr | Q34408283 | ||
| Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation | Q34442495 | ||
| Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer | Q35147520 | ||
| Evaluation of pro-carboxypeptidase A and carboxypeptidase A as serologic markers for adenocarcinoma of the pancreas. | Q36063420 | ||
| Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms | Q36262320 | ||
| Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. | Q38222812 | ||
| The role of neoadjuvant therapy in pancreatic cancer: a review | Q38734981 | ||
| Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer | Q38965713 | ||
| Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets | Q38979712 | ||
| Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy | Q42215457 | ||
| Value of magnetic resonance cholangiopancreatography with secretin stimulation in the evaluation of pancreatic exocrine function after pancreaticogastrostomy | Q45309497 | ||
| CONUT: a tool for controlling nutritional status. First validation in a hospital population. | Q46372238 | ||
| Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test. | Q50622495 | ||
| Long-term outcomes after pancreaticoduodenectomy using pair-watch suturing technique: Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction. | Q53164440 | ||
| Spectrum of imaging findings in the abdomen after radiotherapy. | Q53515704 | ||
| Pathologic response of the pancreas and duodenum to experimental intraoperative irradiation | Q64997636 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience | Q72075526 | ||
| Abdominal radiotherapy is a cause for chronic pancreatitis | Q72898935 | ||
| Duct-parenchymal ratio predicts exocrine pancreatic function after pancreatoduodenectomy and distal pancreatectomy | Q77424605 | ||
| Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma | Q79556524 | ||
| Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery | Q83235167 | ||
| Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators | Q84160301 | ||
| Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4 | Q84968341 | ||
| Noninvasive investigation of exocrine pancreatic function: Feasibility of cine dynamic MRCP with a spatially selective inversion-recovery pulse | Q87064197 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic adenocarcinoma | Q18556189 |
| P304 | page(s) | 5738614 | |
| P577 | publication date | 2019-04-04 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes | |
| P478 | volume | 2019 |
Search more.